Literature DB >> 26951251

Infection and Lupus: Which Causes Which?

Sarah Doaty1, Harsh Agrawal2, Erin Bauer1, Daniel E Furst3,4,5.   

Abstract

Infection is a leading cause of morbidity and mortality among patients with systemic lupus erythematous (SLE). Dysfunction of the innate and adaptive immune systems increases the risk of infection in patients with SLE. Infectious agents have also been theorized to play a role in the pathogenesis of SLE. This article summarizes our current knowledge of the infectious risk SLE patients face as a result of their underlying disease including abnormal phagocytes and T cells as well as the increased risk of infection associated with immunosuppressive agents used to treat disease. Pathogens thought to play a role in the pathogenesis of disease including EBV, CMV, human endogenous retroviruses (HERVs), and tuberculosis will also be reviewed, as well as the pathologic potential of microbial amyloids and the microbiome.

Entities:  

Keywords:  Immunosuppression; Infection; Microbiome; Systemic lupus erythematosus

Mesh:

Substances:

Year:  2016        PMID: 26951251     DOI: 10.1007/s11926-016-0561-4

Source DB:  PubMed          Journal:  Curr Rheumatol Rep        ISSN: 1523-3774            Impact factor:   4.686


  103 in total

1.  Decreased expression of interleukin-2 binding molecules (p70/75) in T cells from patients with systemic lupus erythematosus.

Authors:  T Tanaka; O Saiki; S Negoro; T Igarashi; T Kuritani; H Hara; M Suemura; S Kishimoto
Journal:  Arthritis Rheum       Date:  1989-05

Review 2.  Clinical and molecular evidence for association of SLE with parvovirus B19.

Authors:  M Pavlovic; A Kats; M Cavallo; Y Shoenfeld
Journal:  Lupus       Date:  2010-06       Impact factor: 2.911

3.  Uropathogenic Escherichia coli modulates immune responses and its curli fimbriae interact with the antimicrobial peptide LL-37.

Authors:  Ylva Kai-Larsen; Petra Lüthje; Milan Chromek; Verena Peters; Xiaoda Wang; Asa Holm; Lavinia Kádas; Kjell-Olof Hedlund; Jan Johansson; Matthew R Chapman; Stefan H Jacobson; Ute Römling; Birgitta Agerberth; Annelie Brauner
Journal:  PLoS Pathog       Date:  2010-07-22       Impact factor: 6.823

4.  Toxoplasma gondii infection inhibits the development of lupus-like syndrome in autoimmune (New Zealand Black x New Zealand White) F1 mice.

Authors:  Mei Chen; Fumie Aosai; Kazumi Norose; Hye-Seong Mun; Hiroshi Ishikura; Sachiko Hirose; Lian-Xun Piao; Hao Fang; Akihiko Yano
Journal:  Int Immunol       Date:  2004-05-17       Impact factor: 4.823

5.  Autoimmune neutropenia in systemic lupus erythematosus.

Authors:  G Starkebaum; T H Price; M Y Lee; W P Arend
Journal:  Arthritis Rheum       Date:  1978-06

Review 6.  Parvovirus B19 infection and systemic lupus erythematosus: Activation of an aberrant pathway?

Authors:  Spyros Aslanidis; Athina Pyrpasopoulou; Kostas Kontotasios; Stella Doumas; Chryssanthos Zamboulis
Journal:  Eur J Intern Med       Date:  2007-11-19       Impact factor: 4.487

Review 7.  Systematic review and meta-analysis of the sero-epidemiological association between Epstein-Barr virus and systemic lupus erythematosus.

Authors:  Peter Hanlon; Alison Avenell; Lorna Aucott; Mark A Vickers
Journal:  Arthritis Res Ther       Date:  2014-01-06       Impact factor: 5.156

Review 8.  The value of glucocorticoid co-therapy in different rheumatic diseases--positive and adverse effects.

Authors:  Marlies C van der Goes; Johannes W Jacobs; Johannes W Bijlsma
Journal:  Arthritis Res Ther       Date:  2014-11-13       Impact factor: 5.156

9.  Epstein-Barr virus (EBV)-encoded small RNA is released from EBV-infected cells and activates signaling from Toll-like receptor 3.

Authors:  Dai Iwakiri; Li Zhou; Mrinal Samanta; Misako Matsumoto; Takashi Ebihara; Tsukasa Seya; Shosuke Imai; Mikiya Fujieda; Keisei Kawa; Kenzo Takada
Journal:  J Exp Med       Date:  2009-08-31       Impact factor: 14.307

10.  Human Endogenous Retroviruses (HERVs) and Autoimmune Rheumatic Disease: Is There a Link?

Authors:  Nicola Tugnet; Paul Rylance; Denise Roden; Malgorzata Trela; Paul Nelson
Journal:  Open Rheumatol J       Date:  2013-03-22
View more
  23 in total

Review 1.  Loss of Gut Barrier Integrity In Lupus.

Authors:  Longhuan Ma; Laurence Morel
Journal:  Front Immunol       Date:  2022-06-20       Impact factor: 8.786

2.  Hepatitis B carrier state among SLE patients: case-control study.

Authors:  Omer Gendelman; Naim Mahroum; Doron Comaneshter; Pnina Rotman-Pikielny; Arnon D Cohen; Howard Amital; Michael Sherf
Journal:  Immunol Res       Date:  2017-02       Impact factor: 2.829

Review 3.  Infectious processes and systemic lupus erythematosus.

Authors:  Rebeca Illescas-Montes; Claudia Cristina Corona-Castro; Lucia Melguizo-Rodríguez; Concepción Ruiz; Víctor J Costela-Ruiz
Journal:  Immunology       Date:  2019-08-30       Impact factor: 7.397

4.  Persistent Bacteriuria and Antibodies Recognizing Curli/eDNA Complexes From Escherichia coli Are Linked to Flares in Systemic Lupus Erythematosus.

Authors:  Ryan J Pachucki; Chelsea Corradetti; Lynne Kohler; Jay Ghadiali; Paul M Gallo; Lauren Nicastro; Sarah A Tursi; Stefania Gallucci; Çagla Tükel; Roberto Caricchio
Journal:  Arthritis Rheumatol       Date:  2020-10-11       Impact factor: 10.995

5.  Hospital-acquired infection in patients with systemic lupus erythematosus: a case-control study in a southern Chinese population.

Authors:  Zhongping Zhan; Minxi Lao; Fan Su; Dongying Chen; Liuqin Liang; Xiuyan Yang
Journal:  Clin Rheumatol       Date:  2017-11-27       Impact factor: 3.650

6.  Immune responses to an early lytic cytomegalovirus antigen in systemic lupus erythematosus patients: T-cell responses, cytokine secretions and antibody status.

Authors:  Anette Holck Draborg; Niclas Stefan Rasmussen; Janni Lisander Larsen; Charlotte Sværke Jørgensen; Noreen Sandhu; Kristin Skogstrand; Søren Jacobsen; Gunnar Houen
Journal:  PLoS One       Date:  2018-03-02       Impact factor: 3.240

7.  Miliary Tuberculosis Presenting With Meningitis in a Patient Treated With Mycophenolate for Lupus Nephritis: Challenges in Diagnosis and Review of the Literature.

Authors:  Precious Macauley; Mark Rapp; Sarah Park; Olaoluwatomi Lamikanra; Pratibha Sharma; Michael Marcelin; Kavita Sharma
Journal:  J Investig Med High Impact Case Rep       Date:  2018-04-18

Review 8.  Concomitant new diagnosis of systemic lupus erythematosus and COVID-19 with possible antiphospholipid syndrome. Just a coincidence? A case report and review of intertwining pathophysiology.

Authors:  Eduardo Mantovani Cardoso; Jasmin Hundal; Dominique Feterman; John Magaldi
Journal:  Clin Rheumatol       Date:  2020-07-28       Impact factor: 2.980

9.  Antibodies to periodontogenic bacteria are associated with higher disease activity in lupus patients.

Authors:  Harini Bagavant; Micah L Dunkleberger; Nina Wolska; Magdalena Sroka; Astrid Rasmussen; Indra Adrianto; Courtney Montgomery; Kathy Sivils; Joel M Guthridge; Judith A James; Joan T Merrill; Umesh S Deshmukh
Journal:  Clin Exp Rheumatol       Date:  2018-06-25       Impact factor: 4.862

10.  Systemic Lupus Erythematosus: Definitions, Contexts, Conflicts, Enigmas.

Authors:  Ole Petter Rekvig
Journal:  Front Immunol       Date:  2018-03-01       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.